Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
---|
11/29/1989 | EP0343684A1 Interleukin-1 inhibitors |
11/29/1989 | EP0343654A2 Diol-containing renin inhibitors |
11/29/1989 | EP0343577A2 Des-17-histidine calcitonin |
11/29/1989 | EP0343460A2 P. falciparum CS-peptides as universal T-cell epitope |
11/29/1989 | EP0343388A2 Expression of interferon-gamma in methylotrophic yeasts |
11/29/1989 | EP0343275A1 Process for the production of a high purity, virus-free antihaemophilic factor by means of chromatography |
11/29/1989 | EP0343248A1 Novel polypeptide and method for preparing the same |
11/29/1989 | EP0343186A1 MOLECULES COMPRISING AT LEAST ONE PEPTIDIC SEQUENCE CARRYING ONE OR A PLURALITY OF EPITOPES CHARACTERIZING A PROTEIN PRODUCED BY -i(P. FALCIPARUM) IN HEPATOCYTES AND COMPOSITIONS CONTAINING THEM. |
11/29/1989 | CN1037538A Compounds |
11/29/1989 | CN1037537A Expression of hiv binding proteins |
11/29/1989 | CN1037519A Heterocyclic ketones |
11/28/1989 | US4883865 Hepatitis b virus, solvent extraction, polyoxyethylene glycol and dextran |
11/28/1989 | US4883864 Modified collagen compound and method of preparation |
11/28/1989 | US4883863 Tripeptide derivatives and antiplasmin agents containing the same |
11/28/1989 | US4883861 Cysteine-rich peptides having gamma-glutamic acid and beta-alanine units, a process for their preparation and their use |
11/28/1989 | US4883790 Use of hydro-monobenzoporphyrins to mediate the destruction of unwanted cells or tissues by irradiation |
11/28/1989 | US4883761 Pertussis toxin gene: cloning and expression of protective antigen |
11/28/1989 | US4883754 Bacterial FC receptors |
11/28/1989 | US4883752 Hepatitis b surface antigen |
11/28/1989 | US4883598 Process for isolating coagulation factors, and adsorbent material suitable therefor |
11/28/1989 | CA1263500A1 Gnrh antagonists ii |
11/28/1989 | CA1263499A1 Growth promotants for animals |
11/28/1989 | CA1263329A1 Biologically active substances obtained from bovine casein, process for their preparation and compounds containing the same |
11/28/1989 | CA1263324A1 Method for selecting hybridomas producing antibodies specific to inaccessible cell surface antigens |
11/28/1989 | CA1263307A1 Polydisperse native pseudomonas flagellar (h) antigens and a method of producing them |
11/28/1989 | CA1263305A1 Oral vaccines |
11/23/1989 | EP0343137A1 Fibronectin binding protein |
11/23/1989 | EP0343132A2 Methods and systems for producing HIV antigens |
11/23/1989 | EP0343100A2 Process for the isolation and characterization of a gene-enzyme system for the inactivation of the herbicide phenmedipham |
11/23/1989 | EP0343085A1 Pentapeptides and their use as antithrombotics |
11/23/1989 | EP0342962A2 Peptides having T cell helper activity |
11/23/1989 | EP0342926A2 Plant ubiquitin promoter system |
11/23/1989 | EP0342892A1 Extraction of human interleukin-4 from bacteria |
11/23/1989 | EP0342860A2 Novel protein, sequences containing the gene therefore, vectors, methods of preparation and use |
11/23/1989 | EP0342658A1 Biosynthetic process for the preparation of chemical compounds |
11/23/1989 | EP0342633A2 Transformation du Bacillus thuringiensis |
11/23/1989 | EP0342486A1 Antibiotic |
11/23/1989 | EP0342325A2 Renin-inhibiting amino acid derivatives |
11/23/1989 | EP0342221A1 Portable dna fragments encoding an oxygen-binding protein |
11/23/1989 | EP0342219A1 Protein homologue of human angiogenine |
11/23/1989 | EP0342215A1 Method of diagnosing blood clots using fibrin-binding proteins |
11/23/1989 | EP0342206A1 Human interleukin-3 proteins |
11/23/1989 | DE3915317A1 Verwendung von gonadoliberinderivaten Use of gonadoliberinderivaten |
11/23/1989 | DE3816534A1 Process for the production of natural human interleukin-1 beta (IL-1 beta ) in cell culture |
11/23/1989 | DE3816298A1 Anabolic peptides |
11/21/1989 | US4882425 Receptor specific proteins and their use in receptor typing |
11/21/1989 | US4882424 Activation antigen |
11/21/1989 | US4882422 Pulmonary surfactant proteins |
11/21/1989 | US4882421 Pharmaceutical for treating tumors and method for making it |
11/21/1989 | US4882419 Process for preparing antibiotic L 17392 (deglucoteicoplanin) |
11/21/1989 | US4882282 DNA sequences encoding bovine interleukin-2 |
11/21/1989 | US4882279 Site selective genomic modification of yeast of the genus pichia |
11/21/1989 | US4882278 Immunological protection against cholera |
11/21/1989 | US4882275 Method of purifying endothelial cell growth factors using immobilized heparin |
11/21/1989 | US4882271 Process for preparation of high molecular weight cell-associated protein of campylobacter pylori and use for serological detection of campylobacter pylori infection |
11/21/1989 | US4882268 Method for determining tissue of origin and degree of malignancy of tumor cells |
11/21/1989 | US4882145 T cell epitopes of the hepatitis B virus nucleocapsid protein |
11/16/1989 | WO1989011099A1 Anti-endoserine antibody |
11/16/1989 | WO1989010971A1 Vector for secretion of proteins directly into periplasm or culture medium |
11/16/1989 | WO1989010967A1 Recombinant flagellin vaccines |
11/16/1989 | WO1989010966A1 Vectors encoding hcmv glycoprotein and expression products |
11/16/1989 | WO1989010965A2 Glycoprotein h of herpes viruses |
11/16/1989 | WO1989010964A1 Novel bovine granulocyte-macrophage colony stimulating factor variant |
11/16/1989 | WO1989010962A1 Process for producing a human neutrophil chemotactic factor polypeptide |
11/16/1989 | WO1989010961A1 Peptide analogs and their use as haptens to elicit catalytic antibodies |
11/16/1989 | WO1989010939A1 Immunogens and biologically active peptides derived from shared sequences from antigens and anti-idiotypic antibodies or antibodies specific for cellular receptors of the antigens |
11/16/1989 | WO1989010938A1 Protein micelles |
11/16/1989 | WO1989010937A1 Insulin analogues |
11/16/1989 | WO1989010936A1 Gene for encoding a human malaria vaccine antigen |
11/16/1989 | WO1989010935A1 Atrial peptide derivatives |
11/16/1989 | WO1989010934A1 Procalcitonin peptides |
11/16/1989 | WO1989010933A1 Polypeptide compounds having growth hormone releasing activity |
11/16/1989 | WO1989010932A1 Compositions and method for treating or preventing infections in animals |
11/16/1989 | WO1989010926A1 1,1-dioxo-cephem-4-carbothiolic acid derivatives |
11/16/1989 | WO1989010920A1 Renin inhibitory peptides containing a substituted phenoxyacetyle group |
11/16/1989 | WO1989010760A1 Synthetic peptides for arterial imaging |
11/16/1989 | WO1989010758A1 Compounds, compositions and method for binding bio-affecting substances to surface membranes of bio-particles |
11/16/1989 | WO1989010755A1 Immunogenic complex and its use in vaccination |
11/16/1989 | WO1989010754A1 Therapeutic methods using catalytic antibodies |
11/16/1989 | WO1989009621A3 Compounds for diagnosis and/or therapy of tumours |
11/16/1989 | WO1989009267A3 Dna promoter fragments from wheat |
11/16/1989 | DE3914428A1 Verfahren zur herstellung von gelatine/cyclodextrin-polymeren sowie gelatine/cyclodextrin-copolymere A process for the production of gelatin / cyclodextrin polymers as well as gelatin / cyclodextrin copolymers |
11/16/1989 | DE3910084A1 Polypeptide mit wachstumsfaktor-aktivitaet und nukleinsaeuresequenzen Polypeptides with growth factor activity and nucleic acid sequences of |
11/15/1989 | EP0342173A2 Fibronectin binding protein as well as its preparation |
11/15/1989 | EP0342157A2 Aromatic acids |
11/15/1989 | EP0342128A1 Papillomavirus probes (HPV49, HPV50, HPV54, HPV55), products genetically and immunologically related to this papillomavirus and in vitro methods for the diagnosis of papillomavirus infections and for the production of antibodies against these papillomaviruses |
11/15/1989 | EP0342052A2 Novel monomers for producing coloured polymers; coloured polymers; process for preparing said polymers and for separating substances biologically active trough the use of said polymers |
11/15/1989 | EP0341966A2 Homogeneous mammalian hematopoietic stem cell composition |
11/15/1989 | EP0341963A2 Parathyroid hormone antagonists |
11/15/1989 | EP0341962A2 Humoral hypercalcemic factor antagonists |
11/15/1989 | EP0341935A2 A solid phase process for synthesizing Thymosin alpha 1 |
11/15/1989 | EP0341915A2 Anti-aggregatory peptides |
11/15/1989 | EP0341776A2 Process for the incorporation of DNA molecules into microorganisms with methyl-specific restriction systems |
11/15/1989 | EP0341746A2 Expression of hepatitis B S and preS2 proteins in methylotrophic yeasts |
11/15/1989 | EP0341734A2 Proteins having anti-tumor activity |
11/15/1989 | EP0341733A2 Isolation of HBsAg by immunoaffinity chromatography using the anti-idiotype antibody as an eluting agent |
11/15/1989 | EP0341611A2 Subunit canine parvovirus vaccine and method of making the same |
11/15/1989 | EP0341607A2 Anticoagulant peptide alcohols |
11/15/1989 | EP0341603A2 Atrial peptide derivatives |
11/15/1989 | EP0341477A1 A process for producing a photoprotein aequorin |